TRIM64B

Chr 11

tripartite motif containing 64B

Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response and regulation of gene expression. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]

ResearchGenerating clinical summary…
0
Active trials
2
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
1.30
LOEUF
Multiple*
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.30LOEUF
pLI 0.000
Z-score 0.81
OE 0.75 (0.45–1.30)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
1.34Z-score
OE missense 0.72 (0.63–0.83)
136 obs / 187.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.75 (0.45–1.30)
0≤0.351.4
Missense OE?0.72 (0.63–0.83)
0≤0.61.4
Synonymous OE?0.66
0≤1.21.6
LoF obs/exp: 9 / 12.0Missense obs/exp: 136 / 187.7Syn Z: 2.25

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

TRIM64B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →